Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Sclerotherapy for Treatment of Hemangiomas

Sclerotherapy for Treatment of Hemangiomas Background. While sclerotherapy in chronic venous insufficiency and in hemorrhoids is well established, the use of sclerotherapy for hemangiomas of the skin is widely unknown. Objective. The aim of the study was to analyze the clinical value of sclerotherapy with polidocanol in a larger population. Methods. Over a period of 20 years (1975–1995) we performed sclerotherapy of hemangiomas and vascular malformations in a total of 157 patients. Their ages ranged from 3 months to 75 years. Among these were 87 (55.4%) children and adolescents (up to the age of 18). Sclerotherapy with polidocanol was carried out mostly at monstrous or rapidly growing cavernous hemangiomas mainly localized in the face. Results. One to three injections was usually sufficient to obtain the sclerosis effect; aesthetically, long‐term results were convincing. Severe complications were not observed. Conclusion. Sclerotherapy of hemangiomas is a relatively simple, effective, and inexpensive method that is a valuable and promising treatment. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Dermatologic Surgery Wolters Kluwer Health

Sclerotherapy for Treatment of Hemangiomas

Download PDF
4 pages

Loading next page...
 
/lp/wolters-kluwer-health/sclerotherapy-for-treatment-of-hemangiomas-elC2YXCWF0

References (38)

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2000 Wiley Subscription Services, Inc., A Wiley Company
ISSN
1076-0512
eISSN
1524-4725
DOI
10.1046/j.1524-4725.2000.98012.x
Publisher site
See Article on Publisher Site

Abstract

Background. While sclerotherapy in chronic venous insufficiency and in hemorrhoids is well established, the use of sclerotherapy for hemangiomas of the skin is widely unknown. Objective. The aim of the study was to analyze the clinical value of sclerotherapy with polidocanol in a larger population. Methods. Over a period of 20 years (1975–1995) we performed sclerotherapy of hemangiomas and vascular malformations in a total of 157 patients. Their ages ranged from 3 months to 75 years. Among these were 87 (55.4%) children and adolescents (up to the age of 18). Sclerotherapy with polidocanol was carried out mostly at monstrous or rapidly growing cavernous hemangiomas mainly localized in the face. Results. One to three injections was usually sufficient to obtain the sclerosis effect; aesthetically, long‐term results were convincing. Severe complications were not observed. Conclusion. Sclerotherapy of hemangiomas is a relatively simple, effective, and inexpensive method that is a valuable and promising treatment.

Journal

Dermatologic Surgery – Wolters Kluwer Health

Published: Feb 1, 2000

There are no references for this article.